Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary intervention.
Park MW, Her SH, Kim HS, Choi YS, Park CS, Koh YS, Park HJ, Kim PJ, Kim CJ, Jeon DS, Shin DI, Seo SM, Yoo KD, Kim DB, Kim HY, Lee JM, Chung WS, Seung KB, Shin JG, Chang K.
Park MW, et al. Among authors: park cs, park hj.
Pharmacogenet Genomics. 2013 Oct;23(10):558-62. doi: 10.1097/FPC.0b013e328364eb92.
Pharmacogenet Genomics. 2013.
PMID: 23922007